Shares of biotechs racing to make coronavirus vaccines, including Moderna Inc , fell about 10% on Wednesday, as investor concerns grew about the prospects of the experimental products that are still in early stages of development.
FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease , in Cambridge, Massachusetts, U.S., May 18, 2020. REUTERS/Brian Snyder
Moderna’s stock has more than doubled this year, on the back of early positive data from its experimental vaccine, among the first to be tested in humans in the United States for the virus. “The stock was due for a pullback on some concerns around timing of COVID-19 vaccine deployment,” said Oppenheimer analyst Hartaj Singh.
“We will certainly have doses by the end of the year, I just don’t think we will have data to support widespread inoculation by then,” Scott Gottlieb, former commissioner of the U.S. Food and Drug Administration, said on CNBC.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Novavax begins human trials with potential Covid-19 vaccine in AustraliaNovavax will inject 131 volunteers in the first phase of the trial testing the safety of the vaccine and looking for signs of its effectiveness.
Weiterlesen »
Trump issues Brazil travel ban due to COVID-19FDA Commissioner Dr. Stephen Hahn warns 'the coronavirus is not yet contained' as states begin to open up: 'It is up to every individual to protect themselves and their community.'
Weiterlesen »
L.A. County COVID-19 cases top 46,000 on Memorial DayLos Angeles County reported 12 new coronavirus deaths and an additional 1,047 cases Monday.
Weiterlesen »
Opinion | Trump's failed COVID-19 responses caused the 'American carnage' he once swore to endMore than a million Americans have gotten sick, a hundred thousand are dead and 39 million are unemployed because this president refused to lead.
Weiterlesen »
Australian PM calls for economic overhaul to fuel post COVID-19 recoveryAustralian Prime Minister Scott Morrison on Tuesday called for an ideological truce between employers and workers to revive the country's A$2 trillion ($1.3 trillion) economy, which has been badly damaged by the coronavirus pandemic.
Weiterlesen »